BofA/Merrill Lynch Downgrades Momenta Pharmaceuticals (MNTA) to Underperform

March 19, 2013 7:19 AM EDT
Get Alerts MNTA Hot Sheet
Price: $15.10 --0%

Rating Summary:
    10 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 31 | New: 34
Trade MNTA Now!
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Neutral to Underperform.

For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.

Shares of Momenta Pharmaceuticals closed at $13.86 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Downgrades, Hot Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment